Table 3.
Methods | Compounds | Advantages | Drawbacks | References |
---|---|---|---|---|
ECT | Bleomycin, cisplatin, and carboplatin | Cell toxicity can be enhanced by electroporation Significant antitumor effect on tumor growth and increased tumor ablation zone Significant increase in cell death for the pulmonary metastases of pancreatic cancer |
Postoperative respiratory failure, oxygen sensitivity, alveolar cell damage, and subsequent pulmonary inflammation Strict control of the dosage Clinically difficult injection due to the risk of dissemination of tumor cells |
21,24,32,41,42,43,44,45 |
Calcium electroporation | Calcium | Larger ablation zone Similar therapeutic results as ECT but milder side effects in the treatment of metastatic skin tumors Higher sensitivity to cancer cells than normal cells Low cost of treatment |
Mechanism not fully understood Efficacy in the treatment of large and heterogeneous tumors unknown |
46,48,50,51,76 |
Modification of cell membrane | DMSO and SDS | Less toxic and less harmful to normal tissue Increase in cell membrane permeability Increase in the ablation zone and decrease in the electric threshold value of IRE |
Clinical safety unknown Lack of clinical data Few surfactants available |
52,55,56,69 |
Modifying the microenvironment | Culture medium and glucose | No chemical agents involved Suitable to tumors in a low glucose concentration |
Few modifying methods available Mechanism not fully understood |
57,59,61,62 |
Abbreviations: DMSO, dimethyl sulfoxide; ECT, electrochemotherapy; IRE, irreversible electroporation; SDS, sodium dodecyl sulfate.